ILAE Official Report: A practical clinical definition of epilepsy, Epilepsia, vol.55, issue.4, pp.475-82, 2014. ,
, Organisation Mondiale de la Santé (OMS). (Page consultée le 15/06/2020)
, Organisation Mondiale de la Santé (OMS). (Page consultée le 15/06/2020). Principaux repères sur la dépression
Citing Hippocrates on depression in epilepsy, Epilepsy Behav. 1 janv, vol.90, pp.31-37, 2019. ,
The classification of neuropsychiatric disorders in epilepsy: A proposal by the ILAE Commission on Psychobiology of Epilepsy, Epilepsy Behav. 1 mai, vol.10, issue.3, pp.349-53, 2007. ,
The quality of life of older people with epilepsy: findings from a UK community study, Seizure. 1 mars, vol.10, issue.2, pp.92-101, 2001. ,
Depression and comorbidity in community-based patients with epilepsy or asthma, Neurology. 28 sept, vol.63, issue.6, pp.1008-1022, 2004. ,
The presence and clinical implications of depression in a community population of adults with epilepsy, Epilepsy Behav. 1 févr, vol.8, issue.1, pp.213-222, 2006. ,
Psychiatric comorbidity and suicidal behavior in epilepsy: A community-based case-control study, Epilepsia, vol.51, issue.7, pp.1120-1125, 2010. ,
Depression screening for patients with epilepsy in a primary care setting using the Patient Health Questionnaire-2 and the Neurological Disorders Depression Inventory for Epilepsy, Epilepsy Behav EB. août, vol.21, issue.4, pp.387-90, 2011. ,
The social context of anxiety and depression: Exploring the role of anxiety and depression in the lives of Australian adults with epilepsy, Epilepsy Behav. 1 mai, vol.34, pp.29-33, 2014. ,
The relationship of depression to antiepileptic drug adherence and quality of life in epilepsy, Epilepsy Behav. 1 juill, vol.36, pp.138-181, 2014. ,
Depressiona common disorder across a broad spectrum of neurological conditions: a cross-sectional nationally representative survey, Gen Hosp Psychiatry, vol.37, issue.6, pp.507-519, 2015. ,
What factors contribute to the risk of depression in epilepsy?-Tasmanian Epilepsy Register Mood Study (TERMS), Epilepsia, vol.57, issue.3, pp.516-538, 2016. ,
Prevalence and risk factors of depression and anxiety among patients with convulsive epilepsy in rural West China -Wang -2018 -Acta Neurologica Scandinavica -Wiley Online Library, 2018. ,
Prevalence of epilepsy and comorbidity of psychiatric disorders in Iran. Seizure, vol.15, pp.476-82, 2006. ,
Psychiatric Comorbidity in Epilepsy: A Population-Based Analysis, Epilepsia. 1 déc, vol.48, issue.12, pp.2336-2380, 2007. ,
The association between depression and epilepsy in a nationally representative sample, Epilepsia. 1 mai, vol.50, issue.5, pp.1051-1059, 2009. ,
Epilepsy and psychiatric comorbidity: A nationally representative population-based study, Epilepsia. 1 juin, vol.53, issue.6, pp.1095-103, 2012. ,
Psychosocial issues in people with epilepsy in Togo and Benin (West Africa) I. Anxiety and depression measured using Goldberg's scale, Epilepsy Behav, vol.5, issue.5, pp.722-729, 2004. ,
The Epidemiology of the Comorbidity of Epilepsy in the General Population, Epilepsia. 1 déc, vol.45, issue.12, pp.1613-1635, 2004. ,
Prevalence of Self-Reported Epilepsy or Seizure Disorder and Its Associations with Self-Reported Depression and Anxiety: Results from the 2004 Healthstyles Survey, Epilepsia, vol.47, issue.11, pp.1915-1936, 2006. ,
Comorbidities of epilepsy: Results from the Epilepsy Comorbidities and Health (EPIC) survey, Epilepsia. 1 févr, vol.52, issue.2, pp.308-323, 2011. ,
Emotional and affective disturbances in patients with epilepsy, Epilepsy Behav. 1 juin, vol.3, issue.3, pp.255-61, 2002. ,
Relationship between depression and intractability of seizures, Epilepsy Behav. 1 juin, vol.4, issue.3, pp.298-301, 2003. ,
Depression and anxiety in epilepsy: the association with demographic and seizure-related variables. Ann Gen Psychiatry, vol.6, p.28, 2007. ,
What is the role of depressive symptoms among other predictors of quality of life in people with well-controlled epilepsy on monotherapy?, Epilepsy Behav. 1 mars, vol.20, issue.3, pp.528-560, 2011. ,
Frequency of affective symptoms and their psychosocial impact in Korean people with epilepsy: A survey at two tertiary care hospitals, Epilepsy Behav. 1 janv, vol.26, issue.1, pp.51-57, 2013. ,
Depression but not seizure factors or quality of life predicts suicidality in epilepsy, Epilepsy Behav EB. août, vol.24, issue.4, pp.426-435, 2012. ,
Co-morbidity of depression and epilepsy in Jimma University specialized hospital, Neurol India, 2014. ,
Birhan Tebeje N. Depression among people with epilepsy in Northwest Ethiopia: a cross-sectional institution based study, BMC Res Notes, vol.8, issue.1, p.585, 2015. ,
Impact of depression and anxiety on adverse event profiles in Korean people with epilepsy, Epilepsy Behav. 1 mai, vol.46, pp.185-91, 2015. ,
Depressogenic medications and other risk factors for depression among Polish patients with epilepsy, Neuropsychiatr Dis Treat. 30 sept, vol.11, pp.2509-2526, 2015. ,
Depression and anxiety are associated with reduced antiepileptic drug adherence in Chinese patients, Epilepsy Behav. 1 sept, vol.50, pp.91-96, 2015. ,
Affective symptoms and determinants of health-related quality of life in Mexican people with epilepsy, Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol, vol.38, issue.10, pp.1829-1863, 2017. ,
Factors affecting the quality of life in patients with epilepsy in Seoul, South Korea, Acta Neurol Scand, vol.108, issue.6, pp.428-462, 2003. ,
Quality of life and associated factors among adults with epilepsy in Nigeria, Int J Psychiatry Med, vol.36, issue.4, pp.469-81, 2006. ,
Depression and anxiety disorder among epileptic people at Amanuel Specialized Mental Hospital, 2015. ,
Factors affecting quality of life in adults with epilepsy in Taiwan: A cross-sectional, correlational study, Epilepsy Behav. 1 mai, vol.58, pp.26-32, 2016. ,
Depression in epilepsy is associated with lack of seizure control, Epilepsy Behav, vol.19, issue.3, pp.445-452, 2010. ,
Effects of psychosocial functioning, depression, seizure frequency, and employment on quality of life in patients with epilepsy, Epilepsy Behav. 1 déc, vol.41, pp.18-20, 2014. ,
Depression in people with epilepsy in West China: Status, risk factors and treatment gap, Seizure. mars, vol.66, pp.86-92, 2019. ,
Épidémiologie et facteurs associés au syndrome dépressif chez les patients suivis au centre hospitalo-universitaire de Rennes pour une épilepsie, L'Encéphale. 1 févr, vol.45, issue.1, pp.40-45, 2019. ,
Determination of prevalence of depression in an epilepsy clinic using a brief DSM-IV-based self-report questionnaire, Epilepsy Behav. juill, vol.15, issue.3, pp.362-368, 2009. ,
Quality of life in 1931 adult patients with epilepsy: Seizures do not tell the whole story, Epilepsy Behav. 1 déc, vol.22, issue.4, pp.723-730, 2011. ,
Prevalence of depression and anxiety among patients with epilepsy attending the epilepsy clinic at Sheikh Khalifa Medical City, UAE: A cross-sectional study, Epilepsy Behav, vol.52, pp.194-203, 2015. ,
Prevalence and Predictors of Depression Among Patients With Epilepsy, Stroke, and Multiple Sclerosis Using the Cleveland Clinic Knowledge Program Within the Neurological Institute, Psychosomatics. 1 juill, vol.59, issue.4, pp.369-78, 2018. ,
Depression and quality of life in patients with epilepsy in Northwest Greece, Seizure. mars, vol.66, pp.93-101, 2019. ,
Clinical Assessment of Axis I Psychiatric Morbidity in Chronic Epilepsy: A Multicenter Investigation, J Neuropsychiatry Clin Neurosci. 1 mai, vol.17, issue.2, pp.172-181, 2005. ,
Psychiatric comorbidity, quality of life and social support in epileptic patients, Nord J Psychiatry. déc, vol.65, issue.6, pp.373-80, 2011. ,
Validation of the Italian version of the Neurological Disorders Depression Inventory for Epilepsy (NDDI-E), Epilepsy Behav. 1 juill, vol.24, issue.3, pp.329-360, 2012. ,
Quality of life of patients with epilepsy in Malaysia, Asia-Pac Psychiatry, vol.6, issue.1, pp.105-114, 2014. ,
Assessing the efficacy of 2 screening measures for depression in people with epilepsy, Neurology. 24 juill, vol.79, issue.4, pp.371-376, 2012. ,
Reliability and validity of the Korean version of the Neurological Disorders Depression Inventory for Epilepsy (K-NDDI-E), Epilepsy Behav. 1 déc, vol.25, issue.4, pp.539-581, 2012. ,
Validation of the Spanish version of the Neurological Disorders Depression Inventory for Epilepsy (NDDI-E), Epilepsy Behav. 1 août, vol.24, issue.4, pp.493-499, 2012. ,
Screening for major depressive episodes in Japanese patients with epilepsy: Validation and translation of the Japanese version of Neurological Disorders Depression Inventory for Epilepsy (NDDI-E), Epilepsy Behav. 1 sept, vol.25, issue.1, pp.18-22, 2012. ,
The detection of mood and anxiety in people with epilepsy using two-phase designs: Experiences from a tertiary care centre in Oman, Epilepsy Res. 1 févr, vol.98, issue.2, pp.174-81, 2012. ,
Validating screening tools for depression in epilepsy, Epilepsia, vol.55, issue.10, pp.1642-50, 2014. ,
Study of psychiatric comorbidities in epilepsy by using the Mini International Neuropsychiatric Interview, Epilepsy Behav. 1 avr, vol.33, pp.94-100, 2014. ,
Determinants of depression among patients with epilepsy in Athens, Greece. Epilepsy Behav. 1 avr, vol.33, pp.106-115, 2014. ,
Screening for depression in people with epilepsy: Comparative study among Neurological Disorders Depression Inventory for Epilepsy (NDDI-E), Hospital Anxiety and Depression Scale Depression Subscale (HADS-D), and Beck Depression Inventory (BDI), Epilepsy Behav. 1 mai, vol.34, pp.50-54, 2014. ,
Screening of major depression in epilepsy: The Neurologic Depression Disorders Inventory in Epilepsy-Spanish version (Argentina), Epilepsia, vol.55, issue.2, pp.331-335, 2014. ,
Validation of the Patient Health Questionnaire-9 (PHQ-9) For Depression Screening in Adults with Epilepsy, Epilepsy Behav EB. août, vol.37, pp.215-235, 2014. ,
Reevaluating the prevalence and diagnostic subtypes of depressive disorders in epilepsy, Epilepsy Behav. 1 déc, vol.53, pp.15-24, 2015. ,
Suicidality and Its Risk Factors in Korean People with Epilepsy: A MEPSY Study, J Clin Neurol Seoul Korea. janv, vol.11, issue.1, pp.32-41, 2015. ,
Validation of the Chinese version of the Neurological Disorders Depression Inventory for Epilepsy (C-NDDI-E) in West China, Epilepsy Behav. 1 juin, vol.47, pp.6-10, 2015. ,
Reliability and validity of the Chinese version of the Neurological Disorders Depression Inventory for Epilepsy (C-NDDI-E), Epilepsy Behav. 1 avr, vol.45, pp.225-233, 2015. ,
One step closer to a global tool for rapid screening of major depression in epilepsy: Validation of the French NDDI-E, Epilepsy Behav. 1 mars, vol.44, pp.11-17, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01384022
Depression in patients with epilepsy in Northwestern Nigeria: Prevalence and clinical correlates, Ann Afr Med [Internet]. déc, 2016. ,
Prevalence of psychiatric disorders in Thai patients with epilepsy, Epilepsy Behav EB, vol.90, pp.20-24, 2019. ,
Primidone is associated with interictal depression in patients with epilepsy, Epilepsy Behav. 1 mai, vol.6, issue.3, pp.413-419, 2005. ,
Depressive symptoms in patients with epilepsy: Analysis of self-rating and physician's assessment, Neurol India. 7 janv, vol.58, issue.4, p.565, 2010. ,
Evaluation of clinical aspects and quality of life as risk factors for depression in patients with epilepsy, Seizure. 1 juin, vol.21, issue.5, pp.367-70, 2012. ,
Clinical risk factors for depressive symptoms in patients with epilepsy, Acta Neurol Scand, vol.129, issue.5, pp.343-352, 2014. ,
Validation of a German version of the Neurological Disorders Depression Inventory for Epilepsy (NDDI-E), Epilepsy Behav. 1 déc, vol.25, issue.4, pp.485-493, 2012. ,
What are the predictors of major depression in adult patients with epilepsy?, Epileptic Disord, vol.16, issue.1, pp.74-83, 2014. ,
Validation of the Neurological Disorders Depression Inventory for Epilepsy (NDDI-E) Serbian version, Epilepsy Behav. 1 avr, vol.57, pp.1-4, 2016. ,
The predictors of psychiatric disorders among people living with epilepsy as seen in a Nigerian Tertiary Health Institution, Niger Med J J Niger Med Assoc, vol.57, issue.1, pp.24-30, 2016. ,
Depression but not seizure frequency predicts quality of life in treatment-resistant epilepsy, p.4 ,
Determinants of health-related quality of life in pharmacoresistant epilepsy: Results from a large multicenter study of consecutively enrolled patients using validated quantitative assessments, Epilepsia, vol.52, issue.12, pp.2181-91, 2011. ,
Characteristics associated with quality of life among people with drug-resistant epilepsy, J Neurol, vol.264, issue.6, pp.1174-84, 2017. ,
Risk factors for depression in patients with epilepsy, Epilepsy Behav. 1 mars, vol.8, issue.2, pp.411-418, 2006. ,
Prevalence of depressive symptoms and their impact on quality of life in patients with drug-resistant focal epilepsy (IMDYVA study), Epilepsy Res. 1 févr, vol.110, pp.157-65, 2015. ,
Interictal Depression, Anxiety, Personality Traits, and Psychological Dissociation in Patients with Temporal Lobe Epilepsy (TLE) and Extra-TLE, 2006. ,
Psychiatric disorders in temporal lobe epilepsy: An overview from a tertiary service in Brazil, Seizure, vol.19, issue.8, pp.479-84, 2010. ,
Prevalence of interictal psychiatric disorders in patients with refractory temporal and extratemporal lobe epilepsy in Spain. A comparative study, Epilepsia, vol.51, issue.7, pp.1309-1322, 2010. ,
Is major depressive disorder specifically associated with mesial temporal sclerosis, Epilepsia, vol.53, issue.2, pp.386-92, 2012. ,
Concurrent mood and anxiety disorders are associated with pharmacoresistant seizures in patients with MTLE, Epilepsia, vol.58, issue.7, pp.1268-76, 2017. ,
Depressive disorders in patients with pharmaco-resistant mesial temporal lobe epilepsy, J Int Med Res. févr, vol.46, issue.2, pp.752-60, 2018. ,
Neuropsychiatric morbidity in focal epilepsy, Br J Psychiatry. juin, vol.192, issue.6, pp.464-473, 2008. ,
Do depression symptoms predict seizure frequency-or vice versa?, J Psychosom Res, vol.59, issue.5, pp.269-74, 2005. ,
Individual, seizure-related, and psychosocial predictors of depressive symptoms among people with epilepsy over six months, Epilepsy Behav. 1 juin, vol.15, issue.2, pp.196-201, 2009. ,
Relationships of depression and anxiety symptoms with seizure frequency: Results from a multicenter follow-up study, Seizure. 1 déc, vol.53, pp.103-112, 2017. ,
Frequency and predictors of psychological distress after a diagnosis of epilepsy: A community-based study, Epilepsy Behav, vol.75, pp.190-195, 2017. ,
Factors contributing to anxiety and depressive symptoms in adults with new-onset epilepsy, Epilepsy Behav. 1 nov, vol.88, pp.325-356, 2018. ,
Rapid detection of major depression in epilepsy: a multicentre study, Lancet Neurol. mai, vol.5, issue.5, pp.399-405, 2006. ,
Detecting anxiety and depression in general medical settings, BMJ, vol.297, issue.6653, pp.897-906, 1988. ,
An epidemiological survey of psychiatric disorders in Iran, Clin Pract Epidemiol Ment Health, vol.1, issue.1, p.16, 2005. ,
Epilepsy, suicidality, and psychiatric disorders: A bidirectional association, Ann Neurol. 1 août, vol.72, issue.2, pp.184-91, 2012. ,
Association of Depression and Treated Depression With Epilepsy and Seizure Outcomes, Disponible sur, vol.74, 2017. ,
Sociodemographic and clinical factors associated with depression in epilepsy, Epilepsy Behav. avr, vol.14, issue.4, pp.655-60, 2009. ,
To what extent does depression influence quality of life of people with pharmacoresistant epilepsy in Argentina?, Epilepsy Behav. 1 avr, vol.69, pp.133-141, 2017. ,
Depression in patients receiving pharmacotherapy for epilepsy: An audit in a tertiary care centre, Pharmacol Rep PR, vol.71, issue.5, pp.848-54, 2019. ,
Major depressive disorder in epilepsy clinics: A meta-analysis, Epilepsy Behav. 1 juill, vol.84, pp.56-69, 2018. ,
Depression and quality of life in Spanish-speaking immigrant persons with epilepsy compared with those in English-speaking US-born persons with epilepsy, Epilepsy Behav, vol.51, pp.146-51, 2015. ,
Quality of life and economic impact of refractory epilepsy in Spain: The ESPERA study, Neurol Engl Ed. 1 mai, vol.28, issue.4, pp.195-204, 2013. ,
Rates of DSM-IV mood, anxiety disorders, and suicidality in Australian adult epilepsy outpatients: A comparison of wellcontrolled versus refractory epilepsy, Epilepsy Behav. 1 janv, vol.26, issue.1, pp.29-35, 2013. ,
Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies, Epilepsia, vol.51, issue.6, pp.1069-77, 2010. ,
Depression in patients with temporal lobe epilepsy is related to mesial temporal sclerosis, Epilepsy Res. 3 avr, vol.39, issue.2, pp.121-126, 2000. ,
Medication side effects among people with epilepsy taking phenobarbital in Zambia, Epilepsy Res, vol.108, issue.9, pp.1680-1684, 2014. ,
Cognitive and mood effects of phenobarbital treatment in people with epilepsy in rural China: a prospective study, J Neurol Neurosurg Psychiatry. déc, vol.83, issue.12, pp.1139-1183, 2012. ,
Psychiatric adverse events during vigabatrin therapy, Neurology, vol.53, issue.7, pp.1503-1514, 1999. ,
Effects of vigabatrin on partial seizures and cognitive function, J Neurol Neurosurg Psychiatry. sept, vol.57, issue.9, pp.1057-63, 1994. ,
Safety and efficacy of vigabatrin and carbamazepine in newly diagnosed epilepsy: a multicentre randomised double-blind study. Vigabatrin European Monotherapy Study Group, Lancet Lond Engl. 3 juill, vol.354, issue.9172, pp.13-22, 1999. ,
Vigabatrin vs carbamazepine monotherapy in patients with newly diagnosed epilepsy. A randomized, controlled study, Arch Neurol, vol.52, issue.10, pp.989-96, 1995. ,
Doubleblind, placebo-controlled trial of topiramate (600 mg daily) for the treatment of refractory partial epilepsy, Epilepsia. août, vol.37, issue.8, pp.763-771, 1996. ,
A past psychiatric history may be a risk factor for topiramate-related psychiatric and cognitive adverse events, Epilepsy Behav, vol.4, issue.5, pp.548-52, 2003. ,
The role of titration schedule of topiramate for the development of depression in patients with epilepsy, Epilepsia, vol.50, issue.5, pp.1072-1078, 2009. ,
The Role of Hippocampal Sclerosis in Topiramate-related Depression and Cognitive Deficits in People with Epilepsy, Epilepsia, vol.44, issue.12, pp.1573-1580, 2003. ,
Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy, Epilepsy Res, vol.25, issue.3, pp.217-241, 1996. ,
Efficacy and safety of adjunctive zonisamide therapy for refractory partial seizures, Epilepsy Res. 1 juill, vol.75, issue.2, pp.75-83, 2007. ,
Zonisamide clinical trials: European experience, Seizure. déc, vol.13, 2004. ,
Psychiatric and behavioral side effects of antiepileptic drugs in adults with epilepsy, Epilepsy Behav, vol.76, pp.24-31, 2017. ,
Review of United States and European clinical trials of zonisamide in the treatment of refractory partial-onset seizures, Seizure. déc, vol.13, 2004. ,
Randomized controlled trial of zonisamide for the treatment of refractory partial-onset seizures, Neurology, vol.57, issue.10, pp.1774-1783, 2001. ,
The effect of perampanel on aggression and depression in patients with epilepsy: A short-term prospective study, Seizure. 1 avr, vol.67, pp.1-4, 2019. ,
Final safety, tolerability, and seizure outcomes in patients with focal epilepsy treated with adjunctive perampanel for up to 4 years in an open-label extension of phase III randomized trials: Study 307, Epilepsia, vol.59, issue.4, pp.866-76, 2018. ,
Perampanel in routine clinical use across Europe: Pooled, multicenter, observational data, Epilepsia, vol.59, issue.9, pp.1727-1766, 2018. ,
Perampanel as adjunctive therapy in highly refractory epilepsies: Real-world data from an Italian tertiary care epilepsy centre, J Neurol Sci. 15 juill, vol.390, pp.67-74, 2018. ,
The impact of perampanel treatment on quality of life and psychiatric symptoms in patients with drug-resistant focal epilepsy: An observational study in Italy, Epilepsy Behav, vol.99, p.106391, 2019. ,
Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures, Neurology. 19 févr, vol.70, issue.8, pp.607-623, 2008. ,
Adjunctive levetiracetam in children, adolescents, and adults with primary generalized seizures: Open-label, noncomparative, multicenter, long-term follow-up study, Epilepsia, vol.53, issue.1, pp.111-120, 2012. ,
An open-label study of levetiracetam at individualised doses between 1000 and 3000 mg day?1 in adult patients with refractory epilepsy, Seizure. 1 avr, vol.12, issue.3, pp.141-150, 2003. ,
Efficacy and safety of levetiracetam as adjunctive treatment of refractory partial seizures in a multicentre open-label single-arm trial in Korean patients, Seizure. 1 juill, vol.16, issue.5, pp.402-411, 2007. ,
The SKATE TM study: An open-label community-based study of levetiracetam as add-on therapy for adults with uncontrolled partial epilepsy, Epilepsy Res. 1 août, vol.76, issue.1, pp.6-14, 2007. ,
The KEEPER TM 1KEEPER is a trademark of UCB S.A.1 trial: levetiracetam adjunctive treatment of partial-onset seizures in an open-label community-based study, Epilepsy Res. 1 mai, vol.54, issue.2, pp.153-61, 2003. ,
The long-term efficacy and safety of levetiracetam in a tertiary epilepsy centre, Epileptic Disord Int Epilepsy J Videotape. sept, vol.15, issue.3, pp.302-312, 2013. ,
Psychiatric and behavioral side effects of the newer antiepileptic drugs in adults with epilepsy, Epilepsy Behav. 1 févr, vol.10, issue.1, pp.105-115, 2007. ,
Specific adverse effects of antiepileptic drugs -A true-to-life monotherapy study, Epilepsy Behav. 1 janv, vol.54, pp.150-157, 2016. ,
A systematic review of the behavioral effects of levetiracetam in adults with epilepsy, cognitive disorders, or an anxiety disorder during clinical trials, Epilepsy Behav. 1 avr, vol.4, issue.2, pp.124-156, 2003. ,
The adverse effects profile of levetiracetam in epilepsy: a more detailed look, Int J Neurosci. sept, vol.124, issue.9, pp.627-661, 2014. ,
Assessment of psychiatric and behavioral adverse effects of antiepileptic drugs monotherapy: Could they have a neuroendocrine correlation in persons with epilepsy? Epilepsy Behav, vol.100, p.106439, 2019. ,
Psychiatric Symptoms and Quality of Life in Patients with Drug-Refractory Epilepsy Receiving Adjunctive Levetiracetam Therapy, J Clin Neurol Seoul Korea. sept, vol.7, issue.3, pp.128-164, 2011. ,
Effect of levetiracetam on depression and anxiety in adult epileptic patients, Prog Neuropsychopharmacol Biol Psychiatry. 15 févr, vol.32, issue.2, pp.539-582, 2008. ,
Quality of life, anxiety and depression in adult patients after add-on of levetiracetam and conversion to levetiracetam monotherapy, Epilepsy Res. 1 mars, vol.104, issue.1, pp.140-50, 2013. ,
Tiagabine: the safety landscape, Epilepsia, vol.36, issue.6, pp.10-13, 1995. ,
Tiagabine for complex partial seizures: a randomized, add-on, dose-response trial, Arch Neurol. janv, vol.55, issue.1, pp.56-62, 1998. ,
Depression in epilepsy: A systematic review and meta-analysis, Neurology. 5 févr, vol.80, issue.6, pp.590-599, 2013. ,
Hospitalization for psychiatric disorders before and after onset of unprovoked seizures/epilepsy, Neurology. 7 févr, vol.78, issue.6, pp.396-401, 2012. ,
Major depressive comorbidity in epilepsy as a reactive process to a chronic condition, Epilepsy Behav. 1 févr, vol.8, issue.1, pp.343-347, 2006. ,
Predictors of quality of life and their interrelations in Korean people with epilepsy: A MEPSY study, Seizure, vol.23, issue.9, pp.762-770, 2014. ,
Determinants of quality of life in people with epilepsy and their gender differences, Epilepsy Behav. 1 déc, vol.22, issue.4, pp.692-698, 2011. ,
The Relative Impact of Anxiety, Depression, and Clinical Seizure Features on Health-related Quality of Life in Epilepsy, Epilepsia, vol.45, issue.5, pp.544-50, 2004. ,
The association of mood with quality of life ratings in epilepsy, Neurology. 3 avr, vol.68, issue.14, pp.1101-1108, 2007. ,
Efficacy and tolerability of anti-epileptic drugs-an internet study, Acta Neurol Scand, vol.135, issue.5, pp.533-542, 2017. ,
Severity of anxiety and depression are related to a higher perception of adverse effects of antiepileptic drugs, Seizure, vol.21, issue.8, pp.588-94, 2012. ,
Depressive and anxiety disorders in epilepsy: Do they differ in their potential to worsen common antiepileptic drug-related adverse events, Epilepsia, vol.53, issue.6, pp.1104-1112, 2012. ,
Cross-sensitivity of psychiatric and behavioral side effects with antiepileptic drug use, Seizure. 1 nov, vol.62, pp.38-42, 2018. ,
An evaluation of the impact of memory and mood on antiepileptic drug adherence, Epilepsy Behav. 1 févr, vol.43, pp.61-66, 2015. ,
Refractory epilepsy and nonadherence to drug treatment, Epilepsia Open, vol.4, issue.4, pp.618-641, 2019. ,
Predictors of pharmacoresistant epilepsy, Epilepsy Res. juill, vol.75, issue.2-3, pp.192-198, 2007. ,
Suicidality in temporal lobe epilepsy: Measuring the weight of impulsivity and depression, Epilepsy Behav. 1 déc, vol.22, issue.4, pp.745-754, 2011. ,
Validation of rapid suicidality screening in epilepsy using the NDDIE, Epilepsia, vol.57, issue.6, pp.949-55, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01431269
International consensus clinical practice statements for the treatment of neuropsychiatric conditions associated with epilepsy, Epilepsia, vol.52, issue.11, pp.2133-2141, 2011. ,
Treatment of Interictal Depression with Citalopram in Patients with Epilepsy, Epilepsy Behav. 1 déc, vol.1, issue.6, pp.444-451, 2000. ,
Antidepressive treatment in patients with temporal lobe epilepsy and major depression: a prospective study with three different antidepressants, Epilepsy Behav. 1 déc, vol.4, issue.6, pp.674-683, 2003. ,
The Use of Sertraline in Patients with Epilepsy: Is It Safe?, Epilepsy Behav. 1 avr, vol.1, issue.2, pp.100-105, 2000. ,
The impact of antidepressants on seizure frequency and depressive and anxiety disorders of patients with epilepsy: Is it worth investigating?, Epilepsy Behav. 1 mai, vol.70, pp.5-9, 2017. ,
Citalopram as treatment of depression in patients with epilepsy, Clin Neuropharmacol. juin, vol.27, issue.3, pp.133-139, 2004. ,
Treatment of depressive disorders in epilepsy patients, Epilepsy Behav, vol.3, issue.5, pp.2-9, 2002. ,
Safety of tianeptine use in patients with epilepsy, Epilepsy Behav. 1 mai, vol.34, pp.116-125, 2014. ,
Consensus statement: The evaluation and treatment of people with epilepsy and affective disorders, Epilepsy Behav. 1 juill, vol.13, pp.1-29, 2008. ,
Proconvulsant effects of antidepressants -What is the current evidence?, Epilepsy Behav. 1 août, vol.61, pp.287-91, 2016. ,
Most antidepressant drugs are safe for patients with epilepsy at therapeutic doses: A review of the evidence, Epilepsy Behav. 1 août, vol.61, pp.282-288, 2016. ,
Clinically significant pharmacokinetic drug interactions of antiepileptic drugs with new antidepressants and new antipsychotics, Pharmacol Res. 1 avr, vol.106, pp.72-86, 2016. ,
Anticonvulsants -antidepressants pharmacokinetic drug interactions: the role of the CYP450 system in psychopharmacology, Curr Drug Metab. oct, vol.9, issue.8, pp.730-737, 2008. ,
The pharmacological management of psychiatric comorbidities in patients with epilepsy, Pharmacol Res. 1 mai, vol.107, pp.147-53, 2016. ,
The pharmacological treatment of depression in adults with epilepsy, Expert Opin Pharmacother. déc, vol.9, issue.18, pp.3159-68, 2008. ,
Anticonvulsants in the treatment of major depressive disorder: an overview, Harv Rev Psychiatry, vol.17, issue.4, pp.231-272, 2009. ,
Prescription trends and psychiatric symptoms following first receipt of one of seven common antiepileptic drugs in general practice, Epilepsy Behav. 1 juill, vol.84, pp.49-55, 2018. ,
Electroconvulsive therapy in patients with epilepsy, Epilepsy Behav. 1 sept, vol.9, issue.2, pp.355-364, 2006. ,
Cognitive behavior therapy for depression in people with epilepsy: A systematic review, Epilepsia, vol.54, issue.10, pp.1725-1759, 2013. ,
Self-management for adults with epilepsy: Aggregate Managing Epilepsy Well Network findings on depressive symptoms, Epilepsia, vol.60, issue.9, pp.1921-1952, 2019. ,